Safeguard Scientifics - SFE Stock Forecast, Price & News

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.

Safeguard Scientifics Stock Up 0.2 %

Shares of SFE opened at $4.06 on Thursday. The stock's fifty day simple moving average is $3.97 and its 200-day simple moving average is $4.61. Safeguard Scientifics has a 12-month low of $3.32 and a 12-month high of $8.98.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of Safeguard Scientifics in a report on Wednesday. They issued a "hold" rating for the company.

Insider Buying and Selling

In other Safeguard Scientifics news, major shareholder Thomas A. Satterfield, Jr. bought 13,646 shares of the business's stock in a transaction on Wednesday, May 25th. The shares were bought at an average cost of $3.79 per share, for a total transaction of $51,718.34. Following the transaction, the insider now owns 476,904 shares in the company, valued at approximately $1,807,466.16. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, major shareholder Thomas A. Satterfield, Jr. purchased 29,001 shares of Safeguard Scientifics stock in a transaction dated Thursday, June 9th. The shares were acquired at an average cost of $4.22 per share, for a total transaction of $122,384.22. Following the transaction, the insider now directly owns 618,997 shares of the company's stock, valued at $2,612,167.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Thomas A. Satterfield, Jr. acquired 13,646 shares of the firm's stock in a transaction that occurred on Wednesday, May 25th. The shares were bought at an average cost of $3.79 per share, with a total value of $51,718.34. Following the completion of the purchase, the insider now owns 476,904 shares of the company's stock, valued at $1,807,466.16. The disclosure for this purchase can be found here. Insiders bought a total of 84,588 shares of company stock worth $324,827 over the last three months. 7.10% of the stock is currently owned by company insiders.